Company profile

UPEXI, INC. insider acquisitions

Company CIK 0001775194 · Reported insider acquisitions and filing context.

Company filings at SEC ↗
UPXI · Nasdaq

These are company listings. A transaction is linked to a particular security only when the filing provides enough information.

Company activity summary

By transaction date, as of October 23, 2026.

7 days30 days90 daysOverlapping periods · securities and currencies kept separate

No records are loaded for this 90-day transaction window. This does not establish that no transactions occurred.

Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.MARSHALL ALLANMARSHALL ALLANSalkind GeneSalkind GeneNorstrud Andrew JamesNorstrud Andrew JamesMARSHALL ALLAN · December 23, 2025 · Purchase · Common StockMARSHALL ALLAN · December 16, 2025 · Purchase · Common StockMARSHALL ALLAN · December 15, 2025 · Purchase · Common StockMARSHALL ALLAN · October 1, 2025 · Stock award · Common StockSalkind Gene · November 20, 2025 · Purchase · Common StockNorstrud Andrew James · October 1, 2025 · Stock award · Common StockSalkind Gene · November 17, 2025 · Purchase · Common StockSalkind Gene · November 17, 2025 · Purchase · Common StockOct 1, 2025Dec 23, 2025
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

8 dated transactions · 3 of 3 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Dec 23, 2025UPEXI, INC.Common StockMARSHALL ALLANPurchase
Dec 16, 2025UPEXI, INC.Common StockMARSHALL ALLANPurchase
Dec 15, 2025UPEXI, INC.Common StockMARSHALL ALLANPurchase
Oct 1, 2025UPEXI, INC.Common StockMARSHALL ALLANStock award
Nov 20, 2025UPEXI, INC.Common StockSalkind GenePurchase
Oct 1, 2025UPEXI, INC.Common StockNorstrud Andrew JamesStock award
Nov 17, 2025UPEXI, INC.Common StockSalkind GenePurchase
Nov 17, 2025UPEXI, INC.Common StockSalkind GenePurchase

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Share price & reported acquisitions

Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.

Price history is not available

Market-price history is not connected yet.

UPXI · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.

Reported acquisitions

Filing-date filters apply to the list and timeline. The summary above uses transaction dates.

Reset
Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedReporting ownersType / securityQuantityPrice / reference valueDetails
Trade:
MARSHALL ALLANChief Executive Officer · Director
PurchaseCommon StockNon-derivative security · Code P50,0001.8Value: 90,000Currency not specifiedView ↗
Trade:
MARSHALL ALLANChief Executive Officer · Director
PurchaseCommon StockNon-derivative security · Code P50,0002.07Value: 103,500Currency not specifiedView ↗
Trade:
MARSHALL ALLANChief Executive Officer · Director
PurchaseCommon StockNon-derivative security · Code P100,0002.07Value: 207,000Currency not specifiedView ↗
Trade:
MARSHALL ALLANChief Executive Officer · Director
Stock awardCommon StockNon-derivative security · Code A1,600,0000Value: 0Currency not specifiedView ↗
Trade:
Salkind GeneDirector
PurchaseCommon StockNon-derivative security · Code P50,0002.55Value: 127,500Currency not specifiedView ↗
Trade:
Norstrud Andrew JamesChief Financial Officer · Director
Stock awardCommon StockNon-derivative security · Code A240,0000Value: 0Currency not specifiedView ↗
Trade:
Salkind GeneDirector
PurchaseCommon StockNon-derivative security · Code P100,0002.81Value: 281,000Currency not specifiedView ↗
Trade:
Salkind GeneDirector
PurchaseCommon StockNon-derivative security · Code P100,0002.65Value: 265,000Currency not specifiedView ↗

Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →